Balchem (NASDAQ:BCPC) Stock Price Down 84.6% – What’s Next?

Balchem Co. (NASDAQ:BCPC) traded down 84.6% during trading on Wednesday . The stock traded as low as $163.39 and last traded at $25.11. 4,270 shares changed hands during trading, a decline of 96% from the average session volume of 119,154 shares. The stock had previously closed at $163.39.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. HC Wainwright increased their price target on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Monday, November 4th. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.

Balchem Stock Performance

The company has a market cap of $5.21 billion, a P/E ratio of 43.09, a price-to-earnings-growth ratio of 4.30 and a beta of 0.69. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. The stock has a 50 day moving average price of $165.58 and a two-hundred day moving average price of $170.35.

Balchem Increases Dividend

The company also recently announced an annual dividend, which was paid on Friday, January 17th. Stockholders of record on Thursday, December 26th were paid a dividend of $0.87 per share. The ex-dividend date was Thursday, December 26th. This represents a dividend yield of 0.4%. This is a positive change from Balchem’s previous annual dividend of $0.79. Balchem’s dividend payout ratio (DPR) is 23.39%.

Hedge Funds Weigh In On Balchem

Hedge funds have recently added to or reduced their stakes in the stock. Squarepoint Ops LLC acquired a new stake in shares of Balchem in the 2nd quarter valued at $385,000. Truist Financial Corp boosted its holdings in shares of Balchem by 7.2% in the 2nd quarter. Truist Financial Corp now owns 6,166 shares of the basic materials company’s stock valued at $949,000 after purchasing an additional 415 shares in the last quarter. Handelsbanken Fonder AB boosted its holdings in shares of Balchem by 5.4% in the 3rd quarter. Handelsbanken Fonder AB now owns 7,751 shares of the basic materials company’s stock valued at $1,364,000 after purchasing an additional 400 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of Balchem by 73.4% in the 3rd quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock valued at $148,000 after purchasing an additional 356 shares in the last quarter. Finally, Atomi Financial Group Inc. boosted its holdings in shares of Balchem by 6.1% in the 3rd quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company’s stock valued at $295,000 after purchasing an additional 96 shares in the last quarter. Institutional investors own 87.91% of the company’s stock.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.